MRSA and other resistant bacteria targeted in screening do not spread more easily or cause more severe infections than antibiotic-sensitive bacteria, which are commonly present in the human body. However, if resistant strains cause a serious infection, treatment may be more challenging.
No special preparation is required for collecting screening samples for multidrug-resistant bacteria. Samples are collected in laboratories, inpatient wards, or outpatient clinics.
Depending on the test request, samples may be taken from various parts of the body, including the nasal mucosa, throat, armpits, groin, perineal area, and rectal opening. In some cases, samples may also be collected from wounds or the insertion sites of catheters and cannulas.